UNIVERSITY GENT
Patent Applications and Registrations
Patent applications and USPTO patent grants for UNIVERSITY GENT.The latest application filed is for "mixed-lineage kinase domain-like protein in immunotherapeutic cancer control".
- UNIVERSITY GENT - Gent BE
- UNIVERSITY GENT - Ghent N/A BE
| Patent | Date |
|---|---|
| Mixed-lineage Kinase Domain-like Protein In Immunotherapeutic Cancer Control App 20210121522 - Saelens; Xavier ; et al. | 2021-04-29 |
| Means And Methods For Wound Healing App 20210015965 - HOSTE; Ester ; et al. | 2021-01-21 |
| Cd20 Binding Agents And Uses Thereof App 20190077871 - Tavernier; Jan ; et al. | 2019-03-14 |
| Entity creation for constrained devices Grant 9,866,651 - Ishaq , et al. January 9, 2 | 2018-01-09 |
| Targeted Modified TNF Family Members App 20160159874 - Tavernier; Jan ; et al. | 2016-06-09 |
| Emulating Functionality for Constrained Devices App 20150365467 - Hoebeke; Jeroen ; et al. | 2015-12-17 |
| Entity Creation For Constrained Devices App 20150358430 - Ishaq; Isam ; et al. | 2015-12-10 |
| Hydroxybutyrate And Poly-hydroxybutyrate As Components Of Animal Feed Or Feed Additives App 20100093860 - Boon; Nico ; et al. | 2010-04-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 